Apollo Endosurgery, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Apollo Endosurgery, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q4 2022.
  • Apollo Endosurgery, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2022 was -$9.55M, a 8.19% increase year-over-year.
  • Apollo Endosurgery, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2022 was -$39.8M, a 61.4% decline year-over-year.
  • Apollo Endosurgery, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$39.8M, a 61.4% decline from 2021.
  • Apollo Endosurgery, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$24.7M, a 9.16% decline from 2020.
  • Apollo Endosurgery, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$22.6M, a 17.6% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 -$39.8M -$9.55M +$852K +8.19% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-30
Q3 2022 -$40.7M -$11.4M -$4.79M -71.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-01
Q2 2022 -$35.9M -$10.4M -$7.41M -245% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-02
Q1 2022 -$28.5M -$8.41M -$3.81M -82.9% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-03
Q4 2021 -$24.7M -$10.4M -$6.9M -197% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$17.8M -$6.66M -$4.06M -156% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 -$13.7M -$3.02M +$3.23M +51.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 -$17M -$4.6M +$5.66M +55.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$22.6M -$3.51M -$2.28M -186% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-22
Q3 2020 -$20.3M -$2.6M +$6.06M +70% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 -$26.4M -$6.25M +$2.52M +28.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$28.9M -$10.3M -$1.48M -16.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$27.4M -$1.23M +$17.1M +93.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$44.6M -$8.66M +$1.1M +11.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$45.7M -$8.77M +$767K +8.04% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 -$46.4M -$8.77M -$640K -7.87% Jan 1, 2019 Mar 31, 2019 10-Q 2020-08-04
Q4 2018 -$45.8M -$18.4M -$11M -151% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 -$34.7M -$9.76M -$4.86M -99.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 -$29.9M -$9.54M -$2.68M -39.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-24
Q1 2018 -$27.2M -$8.13M +$83K +1.01% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 -$27.3M -$7.32M +$12.4M +62.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$39.7M -$4.9M +$1.03M +17.4% Jul 1, 2017 Sep 30, 2017 10-Q/A 2018-11-13
Q2 2017 -$40.7M -$6.86M +$2.66M +27.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$43.4M -$8.22M -$2.21M -36.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 -$41.2M -$19.7M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$5.93M Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-26
Q2 2016 -$9.52M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 -$6M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q2 2011 $1.37M +$2.69M Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-12
Q2 2010 -$1.32M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.